ATE114054T1 - Fibrinolytischer test. - Google Patents

Fibrinolytischer test.

Info

Publication number
ATE114054T1
ATE114054T1 AT89313013T AT89313013T ATE114054T1 AT E114054 T1 ATE114054 T1 AT E114054T1 AT 89313013 T AT89313013 T AT 89313013T AT 89313013 T AT89313013 T AT 89313013T AT E114054 T1 ATE114054 T1 AT E114054T1
Authority
AT
Austria
Prior art keywords
labelled
assays
label
fibrinogen
fibrinolytic
Prior art date
Application number
AT89313013T
Other languages
English (en)
Inventor
Mark X Triscott
George J Doellgast
Original Assignee
Elcatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elcatech Inc filed Critical Elcatech Inc
Application granted granted Critical
Publication of ATE114054T1 publication Critical patent/ATE114054T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT89313013T 1988-12-14 1989-12-13 Fibrinolytischer test. ATE114054T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/284,299 US5071745A (en) 1988-12-14 1988-12-14 Fibrinolytic assay

Publications (1)

Publication Number Publication Date
ATE114054T1 true ATE114054T1 (de) 1994-11-15

Family

ID=23089658

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89313013T ATE114054T1 (de) 1988-12-14 1989-12-13 Fibrinolytischer test.

Country Status (6)

Country Link
US (1) US5071745A (de)
EP (1) EP0373908B1 (de)
JP (1) JPH0767396B2 (de)
AT (1) ATE114054T1 (de)
CA (1) CA1339060C (de)
DE (1) DE68919338T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900493A1 (de) * 1989-01-10 1990-07-12 Thomae Gmbh Dr K Verfahren zur bestimmung der fibrinolytischen gesamtaktivitaet im plasma
US5176999A (en) * 1989-12-07 1993-01-05 Eastman Kodak Company Buffered wash composition, insolubilizing composition, test kits and method of use
DE4217474A1 (de) * 1992-05-27 1993-12-02 Boehringer Mannheim Gmbh Verfahren und Mittel zur Bestimmung eines Analyts
US5567596A (en) * 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
US5705353A (en) * 1995-06-07 1998-01-06 Beckman Instruments, Inc. Method of reducing interferences in assays
US6596501B2 (en) 1998-02-23 2003-07-22 Fred Hutchinson Cancer Research Center Method of diagnosing autoimmune disease
US20070196278A1 (en) * 2004-07-29 2007-08-23 Cold Spring Diagnostics, Inc. Compositions and methods for locating an internal bleeding site
US20060024229A1 (en) * 2004-07-29 2006-02-02 Seth Karp Method and product for locating an internal bleeding site
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
EP2890807A4 (de) 2012-07-04 2016-08-03 Aptrix Biosystems LLC Aptamere für priondiagnostika und system für den nachweis von aptamerbindungen
WO2018209244A1 (en) * 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Coagulation and fibrinolysis assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960669A (en) * 1973-01-15 1976-06-01 Association For Pharmacologic Research, Inc. Urine diagnostic test for fibrinolytic activity
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
US3778352A (en) * 1973-02-23 1973-12-11 Baxter Laboratories Inc Plasminogen assay system
US4046635A (en) * 1975-08-27 1977-09-06 Canadian Patents And Development Limited Method for detecting enzymes capable of digesting fibrinogen or fibrin
NL7511055A (nl) * 1975-09-19 1977-03-22 Leuven Res & Dev Vzw Trombosetest.
US4463090A (en) * 1981-09-30 1984-07-31 Harris Curtis C Cascade amplification enzyme immunoassay
DE3336361A1 (de) * 1983-10-06 1985-04-18 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von traegergebundenem fibrin sowie seine verwendung in einem verfahren zur bestimmung von proteinen
US4668621A (en) * 1985-04-22 1987-05-26 Wake Forest University Detecting blood clotting factors with immobilized fibrinogen and labeled fibrinogen

Also Published As

Publication number Publication date
DE68919338T2 (de) 1995-05-24
EP0373908A2 (de) 1990-06-20
EP0373908A3 (en) 1990-11-07
US5071745A (en) 1991-12-10
EP0373908B1 (de) 1994-11-09
DE68919338D1 (de) 1994-12-15
JPH03123498A (ja) 1991-05-27
JPH0767396B2 (ja) 1995-07-26
CA1339060C (en) 1997-07-29

Similar Documents

Publication Publication Date Title
ATE78098T1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
DE68919338D1 (de) Fibrinolytischer Test.
EP0632270A4 (de) Verfahren zur bestimmung der aktivität des blutgerinnungsfaktors xiii und reagentiensatz dafür.
ATE35000T1 (de) Reagenz zur bestimmung der thromboplastinzeit.
ATE315233T1 (de) Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin
EP0236985A3 (en) Method for the photometric determination of protein c and/or protein s activity
ATE22928T1 (de) Verfahren zur bestimmung der wirksamkeit von plasminogen-aktivator des gewebes und zur verwendung in diesem verfahren geeigneter reagenzsatz.
AU8600082A (en) Radioimmunoassay for fibrinopeptide a using a tripeptide thrombin inhibitor
ATE45771T1 (de) Verfahren zur bestimmung des fibrinolytischen zustands von plasma.
US4732860A (en) Process for determining the perkallikrein content and the partial thromboplastin time of a plasma sample
HUT64146A (en) Method and reagent for detecting fibrinogen
DE69032663D1 (de) Enzymtest und testsatz zur messung zellulärer aktivierung
EP0368208A3 (de) Immunoassay-Verfahren und Testsatz dafür
FI932194A0 (fi) Anvaendningen av protrombinfragment
AU620548B2 (en) Process for the quantitative determination of the function and antigenic concentration of a substance contained in a biological liquid
Wiesel et al. Assessment of the Fibrinolytic System
CA2422523A1 (en) Method for measuring the activity of the blood clotting factor xiiia
ATE87037T1 (de) Bestimmung aktiver bestandteile der proteolyse.
KR870008187A (ko) 인체 요 플라스미노겐 활성제 전구체(PRO-uPA) 및 인체 요 플라스미노겐 활성제(u-PA)의 검출 면역흡착-아미도분해법

Legal Events

Date Code Title Description
REZ Deleted due to withdrawal